Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S241000, C548S360100, C549S059000, C514S406000, C514S444000

Reexamination Certificate

active

07125903

ABSTRACT:
The compounds are of the class thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives, useful as D4antagonists. Said compounds are useful for the treatment of medical conditions mediated by inhibition of D4receptor. These conditions comprise, for example, Attention Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, Psychoses, Substance Abuse, Substance Dependence, Parkinson's Disease, Parkinsonism, Tardive Diskinesia, Gilles de la Tourette Syndrome, Conduct Disorder, and Oppositional Defiant Disorder. A further aspect of the invention is to provide a pharmaceutical composition, intermediates, and a method of making said class of compounds.

REFERENCES:
patent: 4075227 (1978-02-01), Jones et al.
patent: 4085114 (1978-04-01), Adachi et al.
patent: 4355037 (1982-10-01), Strupczewski et al.
patent: 4408053 (1983-10-01), Strupczewski et al.
patent: 4408054 (1983-10-01), Strupczewski et al.
patent: 4427691 (1984-01-01), Shutske et al.
patent: 4452804 (1984-06-01), Shutske et al.
patent: 4469869 (1984-09-01), Strupczewski et al.
patent: 4504669 (1985-03-01), Shutske et al.
patent: 4528376 (1985-07-01), Strupczewski et al.
patent: 4644064 (1987-02-01), Shutske et al.
patent: 4728651 (1988-03-01), Ong et al.
patent: 4769472 (1988-09-01), Ong et al.
patent: 5114936 (1992-05-01), Wettlaufer et al.
patent: 5143923 (1992-09-01), Hrib et al.
patent: 5177088 (1993-01-01), Effland et al.
patent: 5180834 (1993-01-01), Wettlaufer et al.
patent: 5225412 (1993-07-01), Hrib et al.
patent: 5225414 (1993-07-01), Henning et al.
patent: 5254595 (1993-10-01), Guzzi et al.
patent: 5256672 (1993-10-01), Wettlaufer et al.
patent: 5321037 (1994-06-01), Nagano et al.
patent: 5328920 (1994-07-01), Effland et al.
patent: 5340833 (1994-08-01), Bridges et al.
patent: 5576319 (1996-11-01), Baker et al.
patent: 5593994 (1997-01-01), Batt et al.
patent: 5696113 (1997-12-01), Palermo et al.
patent: 5780474 (1998-07-01), Peglion et al.
patent: 5843940 (1998-12-01), Cullinan et al.
patent: 5852022 (1998-12-01), Palermo et al.
patent: 5856503 (1999-01-01), Aebi et al.
patent: 5932586 (1999-08-01), Batt et al.
patent: 5965554 (1999-10-01), Palermo et al.
patent: 6008348 (1999-12-01), Palermo et al.
patent: 6022880 (2000-02-01), Effland et al.
patent: 6103724 (2000-08-01), Laszlovszky et al.
patent: 6121293 (2000-09-01), Cullinan et al.
patent: 0058977 (1982-09-01), None
patent: 0221414 (1987-05-01), None
patent: 0729955 (1996-09-01), None
patent: 1269776 (1972-04-01), None
patent: 10095770 (1998-04-01), None
patent: WO 92/08718 (1992-05-01), None
patent: WO 97/23482 (1997-07-01), None
patent: WO 97/28115 (1997-08-01), None
patent: WO 97/40027 (1997-10-01), None
patent: WO 99/40067 (1999-08-01), None
patent: WO 01/19833 (2001-03-01), None
Ong et al (1987): STN International CAPLUS database, Columbus (Ohio), Accession No.,1987:598314.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3618057

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.